Transcatheter Pulmonary Valve Replacement: Evolving Indications and Application

Abstract

The introduction of transcatheter therapy for valvular heart disease has changed the spectrum of care of patients with a variety of cardiovascular conditions. Transcatheter valve placement has become established as a method of treating pathologic regurgitation or stenosis of the pulmonary valve, right ventricular outflow tract or a right ventricle to pulmonary artery conduit. In this review, we examine the pathophysiology of and indications for transcatheter pulmonary valve replacement along with procedural complications. Advancements in clinical application and valve technology will also be covered.

Keywords: :

• cardiac catheterization
• cardiac surgery
• congenital heart disease

Financial & competing interests disclosure

Shabana Shahanavaz is a consultant for Medtronic Inc. (Minneapolis, MI, USA) and a proctor for Edwards Lifesciences (Irvine, CA). DB McElhinney is a consultant for Medtronic, Inc. (Minneapolis, MI, USA). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Company review

In addition to the peer-review process, with the author’s consent, the manufacturer of the product discussed in this article was given the opportunity to review the manuscript for factual accuracy. Changes were made by the author at their discretion and based on scientific or editorial merit only. The author maintained full control over the manuscript, including content, wording and conclusions.